SQLite Web: event

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-10T09:08:57.869901+00:00","dedupe_key":"signal_enriched:discovery_ipo_delta:b1f58e9b0c81d775","evidence_event_ids":["evt_6c09e9d4e814"],"signal_type":"discovery_ipo_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPeWF3ZUVQUTBFbndKMjlTbnZ6SXBhZTlDS0VtWFBBZ2pfVWpiSS1pUkZUcVliRGtZWlpxSGs1bnlQamp2ZXVxTzRBQkhXakhlVVhNTzZONm5WOW9pN1N1UlZDTDQtWmM1MElrY3BRVTZ3TGh6RFVRQVlyNDVWSkJuOEJqT0VwMmJnblZsdmxQeW1GUWhiV3lUWU1jalFJSlVKOWlj?oc=5","as_of":"2026-04-10T09:08:57.869901+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPeWF3ZUVQUTBFbndKMjlTbnZ6SXBhZTlDS0VtWFBBZ2pfVWpiSS1pUkZUcVliRGtZWlpxSGs1bnlQamp2ZXVxTzRBQkhXakhlVVhNTzZONm5WOW9pN1N1UlZDTDQtWmM1MElrY3BRVTZ3TGh6RFVRQVlyNDVWSkJuOEJqT0VwMmJnblZsdmxQeW1GUWhiV3lUWU1jalFJSlVKOWlj?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_3445a237d4acb7bd","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-10T09:13:34.663201+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPeWF3ZUVQUTBFbndKMjlTbnZ6SXBhZTlDS0VtWFBBZ2pfVWpiSS1pUkZUcVliRGtZWlpxSGs1bnlQamp2ZXVxTzRBQkhXakhlVVhNTzZONm5WOW9pN1N1UlZDTDQtWmM1MElrY3BRVTZ3TGh6RFVRQVlyNDVWSkJuOEJqT0VwMmJnblZsdmxQeW1GUWhiV3lUWU1jalFJSlVKOWlj?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"gstatic.com","publisher_resolution":"canonical_aggregator_unresolved","requested_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPeWF3ZUVQUTBFbndKMjlTbnZ6SXBhZTlDS0VtWFBBZ2pfVWpiSS1pUkZUcVliRGtZWlpxSGs1bnlQamp2ZXVxTzRBQkhXakhlVVhNTzZONm5WOW9pN1N1UlZDTDQtWmM1MElrY3BRVTZ3TGh6RFVRQVlyNDVWSkJuOEJqT0VwMmJnblZsdmxQeW1GUWhiV3lUWU1jalFJSlVKOWlj?oc=5","source_event_id":"evt_6c09e9d4e814","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"fb196eba8cb64fd8","kind":"ipo_calendar","published_at":"2026-04-10T08:11:56+00:00","publisher_domain":"gstatic.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.62,"dates_mentioned":[],"entities":[{"asset_class":"equity (IPO-related; symbol not provided)","name":"Oricell","relevance":"primary","symbol":"","type":"company"}],"event_type":"listing","information_gaps":["The provided article text is not actually present (only CSS/HTML boilerplate), so details from the full article cannot be verified.","No information is provided on the funding round type (e.g., Series), investors, valuation, or use-of-proceeds breakdown beyond the headline framing.","No IPO timing, exchange, filing status, or target ticker/symbol is provided.","No technical details on the CAR-T program (target antigen, trial phase, efficacy/safety data) are included in the provided text."],"key_facts":["The signal headline states that Oricell raised $100M.","The raised funds are described as supporting carcinoma CAR-T plans.","The fundraising is described as occurring ahead of an IPO push."],"numeric_claims":[{"label":"fundraising_amount_usd","value":"100M"}],"primary_claim":"China\u2019s Oricell raised $100M for carcinoma CAR-T plans ahead of an IPO push.","relevance_score":0.72,"sentiment":"neutral","source_quality":"high","summary":"Oricell, a China-based biotech, reportedly raised $100M to support its carcinoma CAR-T plans ahead of an IPO push.","topics":["IPO push","fundraising","CAR-T","carcinoma","China biotech"]},"source":"Fierce Biotech","source_domain":"gstatic.com","summary":"China\u2019s Oricell raises $100M for carcinoma CAR-T plans ahead of IPO push Fierce Biotech","tickers":[],"title":"China\u2019s Oricell raises $100M for carcinoma CAR-T plans ahead of IPO push - Fierce Biotech","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — events

Update row 15180 in events